{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:08:43Z","timestamp":1787152123139,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00296-018-4059-4","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T08:22:12Z","timestamp":1527063732000},"page":"1169-1178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8743-3236","authenticated-orcid":false,"given":"Alina","family":"Dima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-7420","authenticated-orcid":false,"given":"Ciprian","family":"Jurcut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-0098","authenticated-orcid":false,"given":"Cristian","family":"Baicus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"issue":"10","key":"4059_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1177\/0961203309106831","volume":"18","author":"R Cervera","year":"2009","unstructured":"Cervera R, Khamashta M, Hughes G (2009) The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus 18(10):869\u2013874. https:\/\/doi.org\/10.1177\/0961203309106831","journal-title":"Lupus"},{"key":"4059_CR2","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1002\/art.21414","volume":"52","author":"CH To","year":"2005","unstructured":"To CH, Petri M (2005) Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 52:4003\u20134010. https:\/\/doi.org\/10.1002\/art.21414","journal-title":"Arthritis Rheum"},{"key":"4059_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0961203307079042","volume":"16","author":"AM Bertoli","year":"2007","unstructured":"Bertoli AM, Vila LM, Apte M et al (2007) Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage. Lupus 16:410\u2013417. https:\/\/doi.org\/10.1177\/0961203307079042","journal-title":"Lupus"},{"key":"4059_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/01.md.0000147737.57861.7c","volume":"83","author":"J Boddaert","year":"2004","unstructured":"Boddaert J, Huong DLT, Amoura Z et al (2004) Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 83:348\u2013359","journal-title":"Medicine (Baltimore)"},{"key":"4059_CR5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4049\/jimmunol.107.5.1281","volume":"107","author":"M Mattioli","year":"1971","unstructured":"Mattioli M, Reichlin M (1971) Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera. J Immunol 107:1281\u20131290","journal-title":"J Immunol"},{"key":"4059_CR6","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/art.20836","volume":"51","author":"E Benito-Garcia","year":"2004","unstructured":"Benito-Garcia E, Schur PH, Lahita R et al (2004) Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests. Arthritis Rheum 51:1030\u20131044. https:\/\/doi.org\/10.1002\/art.20836","journal-title":"Arthritis Rheum"},{"key":"4059_CR7","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.96.3.464","volume":"96","author":"EM Tan","year":"1966","unstructured":"Tan EM, Kunkel HG (1966) Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 96:464\u2013471","journal-title":"J Immunol"},{"key":"4059_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/art.24306","volume":"60","author":"BD Poole","year":"2009","unstructured":"Poole BD, Schneider RI, Guthridge JM et al (2009) Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus. Arthritis Rheum 60:848\u2013859. https:\/\/doi.org\/10.1002\/art.24306","journal-title":"Arthritis Rheum"},{"key":"4059_CR9","first-page":"2055","volume":"23","author":"JM Amigues","year":"1996","unstructured":"Amigues JM, Cantagrel A, Abbal M et al (1996) Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol 23:2055\u20132062","journal-title":"J Rheumatol"},{"key":"4059_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.semarthrit.2011.07.010","volume":"41","author":"S Cappelli","year":"2012","unstructured":"Cappelli S, Bellando RS, Martinovi\u0107 D et al (2012) \u201cTo be or not to be,\u201d ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum 41:589\u201398. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.07.010","journal-title":"Semin Arthritis Rheum"},{"key":"4059_CR11","first-page":"328","volume":"16","author":"D Alarc\u00f3n-Segovia","year":"1989","unstructured":"Alarc\u00f3n-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328\u2013334","journal-title":"J Rheumatol"},{"key":"4059_CR12","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1177\/0961203313508444","volume":"22","author":"A Mesa","year":"2013","unstructured":"Mesa A, Somarelli JA, Wu W et al (2013) Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease. Lupus 22:1371\u20131381. https:\/\/doi.org\/10.1177\/0961203313508444","journal-title":"Lupus"},{"key":"4059_CR13","first-page":"205","volume":"13","author":"RW Hoffman","year":"2012","unstructured":"Hoffman RW, Bezruczko N, Perkins K (2012) An external validation study of a classification of mixed connective tissue disease and systemic lupus erythematosus patients. J Appl Meas 13:205\u2013216","journal-title":"J Appl Meas"},{"key":"4059_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","volume":"57","author":"C Gordon","year":"2017","unstructured":"Gordon C, Amissah-Arthur M-B, Gayed M et al (2017) The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology 57:e1\u2013e45. https:\/\/doi.org\/10.1093\/rheumatology\/kex286","journal-title":"Rheumatology"},{"key":"4059_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/ard.2007.070367","volume":"67","author":"G Bertsias","year":"2008","unstructured":"Bertsias G, Ioannidis JPA, Boletis J et al (2008) EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67:195\u2013205. https:\/\/doi.org\/10.1136\/ard.2007.070367","journal-title":"Ann Rheum Dis"},{"key":"4059_CR16","doi-asserted-by":"publisher","first-page":"321359","DOI":"10.1155\/2014\/321359","volume":"2014","author":"E Cozzani","year":"2014","unstructured":"Cozzani E, Drosera M, Gasparini G et al (2014) Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Dis 2014:321359. https:\/\/doi.org\/10.1155\/2014\/321359","journal-title":"Autoimmune Dis"},{"key":"4059_CR17","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3899\/jrheum.130984","volume":"41","author":"B Artim-Esen","year":"2014","unstructured":"Artim-Esen B, Cene E, ahinkaya Y et al (2014) Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center. J Rheumatol 41:1304\u20131310. https:\/\/doi.org\/10.3899\/jrheum.130984","journal-title":"J Rheumatol"},{"key":"4059_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1136\/ard.51.12.1313","volume":"51","author":"J Vencovsky","year":"1992","unstructured":"Vencovsky J, Williams DG, Field M et al (1992) Clinical associations of IgG antibodies to the ribonucleoprotein p67 polypeptide in patients with systemic lupus erythematosus. Ann Rheum Dis 51:1313\u20131317","journal-title":"Ann Rheum Dis"},{"key":"4059_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/0049-0172(90)90057-M","volume":"20","author":"EJ Ter Borg","year":"1990","unstructured":"Ter Borg EJ, Groen H, Horst G et al (1990) Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus. Semin Arthritis Rheum 20:164\u2013173","journal-title":"Semin Arthritis Rheum"},{"key":"4059_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1191\/0961203302lu144oa","volume":"11","author":"RNV Furtado","year":"2002","unstructured":"Furtado RNV, Pucinelli MLC, Cristo VV et al (2002) Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud\u2019s phenomenon in SLE patients. Lupus 11:35\u201341","journal-title":"Lupus"},{"key":"4059_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1590\/abd1806-4841.20153881","volume":"90","author":"FE Heimovski","year":"2015","unstructured":"Heimovski FE, Simioni JA, Skare TL (2015) Systemic lupus erythematosus and Raynaud\u2019s phenomenon. An Bras Dermatol 90:837\u2013840. https:\/\/doi.org\/10.1590\/abd1806-4841.20153881","journal-title":"An Bras Dermatol"},{"key":"4059_CR22","doi-asserted-by":"publisher","first-page":"e003608","DOI":"10.1136\/bmjopen-2013-003608","volume":"3","author":"M Frodlund","year":"2013","unstructured":"Frodlund M, Dahlstr\u00f6m \u00d6, Kastbom A et al (2013) Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register. BMJ Open 3:e003608. https:\/\/doi.org\/10.1136\/bmjopen-2013-003608","journal-title":"BMJ Open"},{"key":"4059_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jcp.53.6.424","volume":"53","author":"W Egner","year":"2000","unstructured":"Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53:424\u2013432. https:\/\/doi.org\/10.1136\/jcp.53.6.424","journal-title":"J Clin Pathol"},{"key":"4059_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.12.005","author":"ME Munroe","year":"2017","unstructured":"Munroe ME, Vista ES, Merrill JT et al (2017) Pathways of impending disease flare in African-American systemic lupus erythematosus patients. J Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2016.12.005","journal-title":"J Autoimmun"},{"key":"4059_CR25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0889-857X(21)00730-4","volume":"18","author":"J Craft","year":"1992","unstructured":"Craft J (1992) Antibodies to snRNPs in systemic lupus erythematosus. Rheum Dis Clin North Am 18:311\u2013335","journal-title":"Rheum Dis Clin North Am"},{"key":"4059_CR26","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1002\/art.22946","volume":"56","author":"KM Kelly-Scumpia","year":"2007","unstructured":"Kelly-Scumpia KM, Nacionales DC, Scumpia PO et al (2007) In vivo adjuvant activity of the RNA component of the Sm\/RNP lupus autoantigen. Arthritis Rheum 56:3379\u20133386. https:\/\/doi.org\/10.1002\/art.22946","journal-title":"Arthritis Rheum"},{"key":"4059_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/rheumatology\/35.6.534","volume":"35","author":"PG Vlachoyiannopoulos","year":"1996","unstructured":"Vlachoyiannopoulos PG, Guialis A, Tzioufas G et al (1996) Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus. Br J Rheumatol 35:534\u2013541","journal-title":"Br J Rheumatol"},{"key":"4059_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/08916930400022715","volume":"38","author":"P Migliorini","year":"2005","unstructured":"Migliorini P, Baldini C, Rocchi V et al (2005) Anti-Sm and anti-RNP antibodies. Autoimmunity 38:47\u201354. https:\/\/doi.org\/10.1080\/08916930400022715","journal-title":"Autoimmunity"},{"key":"4059_CR29","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/ar2266","volume":"9","author":"M Mahler","year":"2007","unstructured":"Mahler M, Waka A, Hiepe F et al (2007) Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus. Arthritis Res Ther 9:R68. https:\/\/doi.org\/10.1186\/ar2266","journal-title":"Arthritis Res Ther"},{"key":"4059_CR30","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https:\/\/doi.org\/10.1002\/1529-013(199709)40:9<1725::AID-ART29>3.0.CO;2-Y","journal-title":"Arthritis Rheum"},{"key":"4059_CR31","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarcon GS et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"4059_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1128\/CDLI.12.1.107-113.2005","volume":"12","author":"M Mahler","year":"2005","unstructured":"Mahler M, Stinton LM, Fritzler MJ (2005) Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay. Clin Diagn Lab Immunol 12:107\u2013113. https:\/\/doi.org\/10.1128\/CDLI.12.1.107-113.2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"4059_CR33","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1468-3083.2007.02163.x","volume":"21","author":"W Salmhofer","year":"2007","unstructured":"Salmhofer W, Hermann J, Joch M et al (2007) High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease. J Eur Acad Dermatol Venereol 21:1047\u20131053. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02163.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4059_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/rheumatology\/keu343","volume":"54","author":"J Ishizaki","year":"2015","unstructured":"Ishizaki J, Saito K, Nawata M et al (2015) Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. Rheumatology 54:405\u2013412. https:\/\/doi.org\/10.1093\/rheumatology\/keu343","journal-title":"Rheumatology"},{"key":"4059_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","volume":"30","author":"R Gunnarsson","year":"2016","unstructured":"Gunnarsson R, Hetlevik SO, Lilleby V et al (2016) Mixed connective tissue disease. Best Pract Res Clin Rheumatol 30:95\u2013111. https:\/\/doi.org\/10.1016\/j.berh.2016.03.002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4059_CR36","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/art.1780381218","volume":"38","author":"RW Hoffman","year":"1995","unstructured":"Hoffman RW, Sharp GC, Deutscher SL (1995) Analysis of anti-U1 RNA antibodies in patients with connective tissue disease. Association with HLA and clinical manifestations of disease. Arthritis Rheum 38:1837\u20131844","journal-title":"Arthritis Rheum"},{"key":"4059_CR37","unstructured":"Gaubitz M, Wegmann C, Schotte H et al (2002) Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens. Cell Mol Biol (Noisy-le-grand) 48:317\u2013321"},{"key":"4059_CR38","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1136\/ard.2003.013417","volume":"63","author":"IEa Hoffman","year":"2004","unstructured":"Hoffman IEa, Peene I, Meheus L et al (2004) Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 63:1155\u20131158. https:\/\/doi.org\/10.1136\/ard.2003.013417","journal-title":"Ann Rheum Dis"},{"key":"4059_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.0105-2896.2009.00863.x","volume":"233","author":"NH Kattah","year":"2010","unstructured":"Kattah NH, Kattah MG, Utz PJ (2010) The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases. Immunol Rev 233:126\u2013145. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00863.x","journal-title":"Immunol Rev"},{"key":"4059_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/BOR.0000000000000199","volume":"27","author":"R Bourn","year":"2015","unstructured":"Bourn R, James JA (2015) Preclinical lupus. Curr Opin Rheumatol 27:433\u2013439. https:\/\/doi.org\/10.1097\/BOR.0000000000000199","journal-title":"Curr Opin Rheumatol"},{"key":"4059_CR41","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/art.39804","volume":"68","author":"HM Berens-Norman","year":"2016","unstructured":"Berens-Norman HM, Boackle SA. Editorial (2016) Subduing lupus: can preclinical autoimmune disease be arrested? Arthritis Rheumatol 68:2357\u20132360. https:\/\/doi.org\/10.1002\/art.39804","journal-title":"Arthritis Rheumatol"},{"key":"4059_CR42","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526\u20131533. https:\/\/doi.org\/10.1056\/NEJMoa021933","journal-title":"N Engl J Med"},{"key":"4059_CR43","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1172\/JCI106502","volume":"50","author":"GC Sharp","year":"1971","unstructured":"Sharp GC, Irvin WS, LaRoque RL et al (1971) Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest 50:350\u2013359. https:\/\/doi.org\/10.1172\/JCI106502","journal-title":"J Clin Invest"},{"key":"4059_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"Sharp GC, Irvin WS, Tan EM et al (1972) Mixed connective tissue disease\u2013an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148\u2013159","journal-title":"Am J Med"},{"key":"4059_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/tan.12027","volume":"81","author":"K Yoshida","year":"2013","unstructured":"Yoshida K, Inoue H, Komai K et al (2013) Mixed connective tissue disease is distinct from systemic lupus erythematosus: study of major histocompatibility complex class I polypeptide-related sequence A and HLA gene polymorphisms. Tissue Antigens 81:44\u201345. https:\/\/doi.org\/10.1111\/tan.12027","journal-title":"Tissue Antigens"},{"key":"4059_CR46","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3109\/14397595.2013.863442","volume":"24","author":"M Washio","year":"2014","unstructured":"Washio M, Fujii T, Kuwana M et al (2014) Lifestyle and other related factors for the development of mixed connective tissue disease among Japanese females in comparison with systemic lupus erythematosus. Mod Rheumatol 24:788\u2013792. https:\/\/doi.org\/10.3109\/14397595.2013.863442","journal-title":"Mod Rheumatol"},{"key":"4059_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0961203316655212","volume":"26","author":"A Mesa","year":"2016","unstructured":"Mesa A, Fernandez M, Wu W et al (2016) Can SLE classification rules be effectively applied to diagnose unclear SLE cases? Lupus 26:150\u2013162. https:\/\/doi.org\/10.1177\/0961203316655212","journal-title":"Cases? Lupus"},{"key":"4059_CR48","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0961203315575586","volume":"24","author":"MF Carpintero","year":"2015","unstructured":"Carpintero MF, Martinez L, Fernandez I et al (2015) Diagnosis and risk stratification in patients with anti-RNP autoimmunity. Lupus 24:1057\u20131066. https:\/\/doi.org\/10.1177\/0961203315575586","journal-title":"Lupus"},{"key":"4059_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jbspin.2015.07.002","volume":"83","author":"A Guffroy","year":"2016","unstructured":"Guffroy A, Dima A, Nespola B et al (2016) Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE. Jt Bone Spine 83:330\u2013334. https:\/\/doi.org\/10.1016\/j.jbspin.2015.07.002","journal-title":"Jt Bone Spine"},{"key":"4059_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2177\/jsci.31.405","volume":"31","author":"T Miyamae","year":"2008","unstructured":"Miyamae T, Ito S, Machida H et al (2008) Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody. Nihon Rinsho Meneki Gakkai Kaishi 31:405\u2013414","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"4059_CR51","doi-asserted-by":"publisher","first-page":"e32001","DOI":"10.1371\/journal.pone.0032001","volume":"7","author":"KH Ching","year":"2012","unstructured":"Ching KH, Burbelo PD, Tipton C et al (2012) Two major autoantibody clusters in systemic lupus erythematosus. PLoS One 7:e32001. https:\/\/doi.org\/10.1371\/journal.pone.0032001","journal-title":"PLoS One"},{"key":"4059_CR52","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3899\/jrheum.080588","volume":"36","author":"R Jurenc\u00e1k","year":"2009","unstructured":"Jurenc\u00e1k R, Fritzler M, Tyrrell P et al (2009) Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol 36:416\u2013421. https:\/\/doi.org\/10.3899\/jrheum.080588","journal-title":"J Rheumatol"},{"key":"4059_CR53","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1136\/ard.62.6.556","volume":"62","author":"P Alba","year":"2003","unstructured":"Alba P, Bento L, Cuadrado MJ et al (2003) Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 62:556\u2013560","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4059_CR54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1191\/0961203302lu158oa","volume":"11","author":"H Bastian","year":"2002","unstructured":"Bastian H, Roseman J, Mcgwin G et al (2002) Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 11(3):152\u2013160. https:\/\/doi.org\/10.1191\/0961203302lu158oa","journal-title":"Lupus"},{"key":"4059_CR55","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2014.01.020","volume":"48\u201349","author":"E Maverakis","year":"2014","unstructured":"Maverakis E, Patel F, Kronenberg DG et al (2014) International consensus criteria for the diagnosis of Raynaud\u2019s phenomenon. J Autoimmun 48\u201349:60\u201365. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.020","journal-title":"J Autoimmun"},{"key":"4059_CR56","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00296-012-2449-6","volume":"33","author":"S Pavlov-Dolijanovic","year":"2013","unstructured":"Pavlov-Dolijanovic S, Damjanov NS, Vujasinovic Stupar NZ et al (2013) Is there a difference in systemic lupus erythematosus with and without Raynaud\u2019s phenomenon? Rheumatol Int 33:859\u2013865. https:\/\/doi.org\/10.1007\/s00296-012-2449-6","journal-title":"Rheumatol Int"},{"key":"4059_CR57","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1007\/s00296-011-2109-2","volume":"32","author":"S Pavlov-Dolijanovic","year":"2012","unstructured":"Pavlov-Dolijanovic S, Damjanov NS, Stojanovic RM et al (2012) Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud\u2019s phenomenon. Rheumatol Int 32:3039\u20133045. https:\/\/doi.org\/10.1007\/s00296-011-2109-2","journal-title":"Rheumatol Int"},{"key":"4059_CR58","doi-asserted-by":"publisher","unstructured":"Huang C, Li M, Liu Y et al Baseline characteristics and risk factors of pulmonary arterial hypertension in systemic lupus erythematosus patients. https:\/\/doi.org\/10.1097\/MD.0000000000002761","DOI":"10.1097\/MD.0000000000002761"},{"issue":"1","key":"4059_CR59","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.chest.2017.08.014","volume":"153","author":"E Hachulla","year":"2018","unstructured":"Hachulla E, Jais X, Cinquetti G et al (2018) Pulmonary arterial hypertension associated with systemic lupus erythematosus. Chest 153(1):143\u2013151.\u00a0 https:\/\/doi.org\/10.1016\/j.chest.2017.08.014","journal-title":"Chest"},{"key":"4059_CR60","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ijcard.2017.01.097","volume":"236","author":"J Zhao","year":"2017","unstructured":"Zhao J, Wang Q, Liu Y et al (2017) Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China. Int J Cardiol 236:432\u2013437. https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.097","journal-title":"Int J Cardiol"},{"key":"4059_CR61","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s10067-013-2307-2","volume":"32","author":"X Yang","year":"2013","unstructured":"Yang X, Mardekian J, Sanders KN et al (2013) Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature. Clin Rheumatol 32:1519\u20131531. https:\/\/doi.org\/10.1007\/s10067-013-2307-2","journal-title":"Clin Rheumatol"},{"key":"4059_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/OARRR.S123549","volume":"9","author":"K Tselios","year":"2016","unstructured":"Tselios K, Gladman D, Urowitz M (2016) Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. Open Access Rheumatol Res Rev 9:1\u20139. https:\/\/doi.org\/10.2147\/OARRR.S123549","journal-title":"Open Access Rheumatol Res Rev"},{"key":"4059_CR63","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jbspin.2015.05.013","volume":"83","author":"S Tellier","year":"2016","unstructured":"Tellier S, Bader-Meunier B, Quartier P et al (2016) Initial presentation and outcome of pediatric-onset mixed connective tissue disease: A French multicenter retrospective study. Jt Bone Spine 83:369\u2013371. https:\/\/doi.org\/10.1016\/j.jbspin.2015.05.013","journal-title":"Jt Bone Spine"},{"key":"4059_CR64","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.lpm.2010.06.008","volume":"39","author":"J Sibilia","year":"2010","unstructured":"Sibilia J, Chatelus E, Meyer A et al (2010) Comment faire le diagnostic et mieux comprendre les myopathies inflammatoires ? L\u2019utilit\u00e9 des auto-anticorps. Presse Med 39:1010\u20131025. https:\/\/doi.org\/10.1016\/j.lpm.2010.06.008","journal-title":"Presse Med"},{"key":"4059_CR65","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1002\/art.27700","volume":"62","author":"T Sato","year":"2010","unstructured":"Sato T, Fujii T, Yokoyama T et al (2010) Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum 62:3730\u20133740. https:\/\/doi.org\/10.1002\/art.27700","journal-title":"Arthritis Rheum"},{"key":"4059_CR66","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2332\/allergolint.14-RAI-0801","volume":"63","author":"T Fujii","year":"2014","unstructured":"Fujii T (2014) Direct and indirect pathogenic roles of autoantibodies in systemic autoimmune diseases. Allergol Int 63:515\u2013522. https:\/\/doi.org\/10.2332\/allergolint.14-RAI-0801","journal-title":"Allergol Int"},{"key":"4059_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/s10165-012-0624-y","volume":"23","author":"Y Katsumata","year":"2013","unstructured":"Katsumata Y, Kawaguchi Y, Baba S et al (2013) Serum antibodies against the 70\u00a0k polypeptides of the U1 ribonucleoprotein complex are associated with psychiatric syndromes in systemic lupus erythematosus: a retrospective study. Mod Rheumatol 23:71\u201380. https:\/\/doi.org\/10.1007\/s10165-012-0624-y","journal-title":"Mod Rheumatol"},{"key":"4059_CR68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/1529-0131(199901)42:1<69::AID-ANR9>3.0.CO;2-J","volume":"42","author":"M Reichlin","year":"1999","unstructured":"Reichlin M, Broyles TF, Hubscher O et al (1999) Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum 42:69\u201375. https:\/\/doi.org\/10.1002\/1529-0131(199901)42:1<69::AID-ANR9>3.0.CO;2-J","journal-title":"Arthritis Rheum"},{"key":"4059_CR69","first-page":"80","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5:80\u201393","journal-title":"Arthritis Res Ther"},{"key":"4059_CR70","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1046\/j.1523-1747.2003.12028.x","volume":"120","author":"Y Asano","year":"2003","unstructured":"Asano Y, Ihn H, Yamane K et al (2003) The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis. J Invest Dermatol 120:204\u2013210. https:\/\/doi.org\/10.1046\/j.1523-1747.2003.12028.x","journal-title":"J Invest Dermatol"},{"key":"4059_CR71","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/art.27224","volume":"62","author":"S Assassi","year":"2010","unstructured":"Assassi S, Mayes MD, Arnett FC et al (2010) Systemic sclerosis and lupus: points in an interferon-mediated continuum. Arthritis Rheum 62:589\u2013598. https:\/\/doi.org\/10.1002\/art.27224","journal-title":"Arthritis Rheum"},{"key":"4059_CR72","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2133.2007.08392.x","volume":"158","author":"Y Hamaguchi","year":"2008","unstructured":"Hamaguchi Y, Hasegawa M, Fujimoto M et al (2008) The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol 158:487\u2013495. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08392.x","journal-title":"Br J Dermatol"},{"key":"4059_CR73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/RHU.0000000000000500","volume":"23","author":"L Escol\u00e0-Verg\u00e9","year":"2017","unstructured":"Escol\u00e0-Verg\u00e9 L, Pinal-Fernandez I, Fernandez-Codina A et al (2017) Mixed connective tissue disease and epitope spreading. J Clin Rheumatol 23:155\u2013159. https:\/\/doi.org\/10.1097\/RHU.0000000000000500","journal-title":"J Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4059-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4059-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4059-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:33:28Z","timestamp":1693683208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4059-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4059"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4059-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"21 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors received any fees, honoraria, grants or consultancies that would constitute a conflict of interest with the current study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}